Policy catalysts

Policy catalysts and events, newest first.

DateCardAvg 5d

2026-09-09EU General Court dismisses Hungary challenge over using frozen Russian assets for UkraineEURUSD RUB SAAB-B.ST
2026-09-09Hungary loses legal bid against EU plan to use Russian asset windfall for UkraineEURHUF HUF SXPARO
2026-09-09Hong Kong says its Buildings Department will tighten scaffold-net inspections and building-repair rules3311.HK HKRE
2026-09-09Hong Kong's Building Department tightens scaffold-net safety checks after Wang Fuk Court fire00016.HK HKREI
2026-09-09European Commission publishes European Innovation Act to boost EU growthEURUSD STOXX600 SX8E
2026-09-09Hong Kong Development Bureau steps up building-safety inspections and plans tighter repair-work rules after Wang Fuk Court fireHKEX:0011 HKEX:0833 HKEX:3311
2026-09-09European Commission publishes European Innovation Act to boost EU growthEURUSD STOXX600 SX8E
2026-09-09European Parliament schedules draft report on a Pact for the MediterraneanBRENT TURKGB10Y
2026-09-09VoIP-Pal Files Third Amended Antitrust Suit Against AT&T, Verizon, T-MobileT TMUS VZ-0.61%
2026-09-09Vistra Drops 30% from High Amid PJM Regulatory Scrutiny and Battery OutagesVST
2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee for Nuclear RestartSPY-1.10%
2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
2026-09-09UBS Upgrades Lockheed Martin to Buy Citing 3.2x Book-to-Bill RatioLMT+2.44%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityGOOGL
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee for Duane Arnold Nuclear RestartVST
2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
2026-09-09Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 BacklogITA-1.90%
2026-09-09CRISPR Therapeutics Expands Casgevy Pediatric Label After 78% QoQ Sales JumpCRSP VRTX-1.51%
2026-09-09Lockheed Martin Upgraded at UBS on 3.2x Book-to-Bill and F-35 Sales GrowthSPY-1.10%
2026-09-09Lockheed Martin Upgraded at UBS on 3.2x Book-to-Bill and F-35 Sales OutlookLMT RTX+1.04%
2026-09-09CRISPR Therapeutics Gains FDA Pediatric Approval for Casgevy as Sales Hit $76MVRTX-1.51%
2026-09-09Fed Hike Odds Cross 60% as Digital Assets and Rate Sensitives SoftenDXY TLT-1.04%
2026-09-09NextEra Energy Secures $1.9B DOE Loan Guarantee for Duane Arnold RestartNEE VST
2026-09-09Vistra Drops 30% to $154 as PJM Scrutiny and Outages Compress ValuationSPY-1.10%
2026-09-09Vistra Drops 30% from Record Highs Amid PJM Regulatory ScrutinyUSO+4.13%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityNEE
2026-09-09Lockheed Martin Upgraded at UBS on 3.2x Book-to-Bill and F-35 Sales OutlookLMT RTX+1.04%
2026-09-09CRISPR Therapeutics Expands Casgevy Pediatric Label After 78% QoQ Sales JumpCRSP VRTX-1.51%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear PlantGOOGL NEE
2026-09-09Vistra Drops 30% from Peak Amid PJM Regulatory Challenges and Storage OutagesNRG VST
2026-09-09VoIP-Pal Amends Federal Antitrust Complaint Against Major US CarriersT TMUS VZ-0.61%
2026-09-09Vistra Drops 30% from High Amid PJM Regulatory Scrutiny and Battery OutagesVST XLU-3.77%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityNEE SPY-1.10%
2026-09-09VoIP-Pal Files Third Amended Antitrust Complaint Against Major TelecomsT TMUS VZ-0.61%
2026-09-09NextEra Energy Secures $1.9B DOE Loan Guarantee for Duane Arnold RestartNEE VST
2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityGOOGL NEE
2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
2026-09-09Fed Hike Odds Cross 60% as Digital Assets and Rate Sensitives SoftenDXY SPY TLT-1.07%
2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
2026-09-09CRISPR Therapeutics Gains FDA Pediatric Approval for Casgevy as Sales Hit $76MCRSP VRTX-1.51%
2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients Aged 2+CRSP VRTX-1.51%
2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
2026-09-09NextEra secures $1.9B DOE loan guarantee to restart Iowa nuclear facilityNEE
2026-09-09Vistra Pulls Back 30% to $154 Amid Battery Outages and PJM Regulatory HeadwindsVST
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee for Duane Arnold Nuclear RestartNEE VST
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart 615 MW Duane Arnold Nuclear PlantGOOGL NEE
2026-09-09Vistra Drops 30% on Battery Outages and PJM Interconnection ScrutinyVST

See today's live cards

Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

Open Desk — $399/month